Literature DB >> 15618650

Evaluation of blood-brain barrier transporters by co-culture of brain capillary endothelial cells with astrocytes.

Yasuto Kido1, Ikumi Tamai, Takeo Nakanishi, Toru Kagami, Iori Hirosawa, Yoshimichi Sai, Akira Tsuji.   

Abstract

To investigate the transport function of the blood-brain barrier (BBB), we employed an in vitro model of the BBB, consisting of a co-culture of porcine brain capillary endothelial cells (BCECs) with rat astrocytes. Porcine BCECs were cultured on a filter insert with rat astrocytes on the underlying plastic well. Rat astrocytes induced characteristic BBB properties of porcine BCECs, such as gamma-glutamyl-transpeptidase activity and intercellular adhesion of porcine BCECs. Next, the transport properties of P-glycoprotein (P-gp) substrate and several anionic compounds across the co-cultured porcine BCECs were characterized. Expression of P-gp was detected by immunocytochemistry, and efflux-directed transport of the P-gp substrate [(3)H]daunomycin was observed. Luminal-to-abluminal transport of the monocarboxylic acid transporter 1 (MCT1) substrate [(14)C]benzoic acid was saturable, and the K(m) value (3.05 mM) was similar to that for brain uptake observed in vivo. Abluminal-to-luminal transport of [(14)C]benzoic acid was also saturable, indicating that the monocarboxylic acid transporter of the BBB contributes to the efflux from the brain as well as to blood-to-brain influx. Abluminal-to-luminal transport of organic anions, [(3)H]dehydroepiandrosterone sulfate, [(3)H]estrone sulfate and [(3)H]estradiol 17beta-D-glucuronide was significantly higher than the corresponding luminal-to-abluminal transport. These results demonstrate the presence of multiple efflux transport pathways in this in vitro model.

Entities:  

Year:  2002        PMID: 15618650     DOI: 10.2133/dmpk.17.34

Source DB:  PubMed          Journal:  Drug Metab Pharmacokinet        ISSN: 1347-4367            Impact factor:   3.614


  7 in total

1.  Mrp4 confers resistance to topotecan and protects the brain from chemotherapy.

Authors:  Markos Leggas; Masashi Adachi; George L Scheffer; Daxi Sun; Peter Wielinga; Guoqing Du; Kelly E Mercer; Yanli Zhuang; John C Panetta; Brad Johnston; Rik J Scheper; Clinton F Stewart; John D Schuetz
Journal:  Mol Cell Biol       Date:  2004-09       Impact factor: 4.272

Review 2.  Vascular cognitive impairment: Modeling a critical neurologic disease in vitro and in vivo.

Authors:  Alex M Helman; M Paul Murphy
Journal:  Biochim Biophys Acta       Date:  2015-12-17

3.  Establishment of a simplified in vitro porcine blood-brain barrier model with high transendothelial electrical resistance.

Authors:  Adjanie Patabendige; Robert A Skinner; N Joan Abbott
Journal:  Brain Res       Date:  2012-07-10       Impact factor: 3.252

4.  Constructive remodeling of a synthetic endothelial extracellular matrix.

Authors:  Sewoon Han; Yoojin Shin; Hyo Eun Jeong; Jessie S Jeon; Roger D Kamm; Dongeun Huh; Lydia L Sohn; Seok Chung
Journal:  Sci Rep       Date:  2015-12-21       Impact factor: 4.379

5.  A novel blood-brain barrier co-culture system for drug targeting of Alzheimer's disease: establishment by using acitretin as a model drug.

Authors:  Christian Freese; Sven Reinhardt; Gudrun Hefner; Ronald E Unger; C James Kirkpatrick; Kristina Endres
Journal:  PLoS One       Date:  2014-03-07       Impact factor: 3.240

6.  A detailed method for preparation of a functional and flexible blood-brain barrier model using porcine brain endothelial cells.

Authors:  Adjanie Patabendige; Robert A Skinner; Louise Morgan; N Joan Abbott
Journal:  Brain Res       Date:  2013-04-17       Impact factor: 3.252

7.  Hypoxic Stress Induced by Hydralazine Leads to a Loss of Blood-Brain Barrier Integrity and an Increase in Efflux Transporter Activity.

Authors:  Morgane Chatard; Clémentine Puech; Frederic Roche; Nathalie Perek
Journal:  PLoS One       Date:  2016-06-23       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.